Engineering Mesenchymal Stem Cells for Regenerative Medicine

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 1505

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biomedical Engineering, Jungwon University, Goesan-gun, Republic of Korea
Interests: tissue engineering; regenerative medicine; mesenchymal stem cell; stem cells

E-Mail Website
Guest Editor
Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA
Interests: stem cells; pluripotent; cancer stem cells; extracellular matrix; artificial stem cell niches; microenvironment; regenerative medicine; organoids

Special Issue Information

Dear Colleagues,

Mesenchymal stem cells (MSCs) have emerged as a powerful tool in regenerative medicine due to their multipotency, immunomodulatory properties, and ability to secrete bioactive factors that promote tissue regeneration. This Special Issue focuses on the latest advancements in engineering MSCs to enhance their therapeutic potential, including genetic modifications, biomaterial integration, bioactive factor secretion, and improved protocols for their derivation from tissues, pluripotent stem cells, and direct reprogramming, as well as their characterization and differentiation. We aim to explore novel strategies that optimize MSC-based therapies, address challenges such as immune rejection and viability loss, and accelerate clinical translation. This Special Issue welcomes original research and comprehensive reviews on MSC-based biomaterials, mechanistic insights into MSC differentiation, engineered MSC therapies for specific diseases, advances in cell delivery and storage systems, and the role of secreted bioactive factors in tissue repair. By bringing together cutting-edge research, this Special Issue will provide a comprehensive outlook on the future of MSC engineering in regenerative medicine.

Dr. Kyungsook Kim
Dr. Luis G. Villa-Diaz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesenchymal stem cell (MSC) engineering
  • genetic modification of MSCs
  • MSC biomaterial integration
  • surface modification of MSCs
  • MSC sheet engineering
  • scaffold-free MSC delivery
  • MSC bioactive factor secretion
  • direct MSC reprogramming
  • engineered MSC characterization and differentiation
  • improved protocols for MSC derivation from tissues and pluripotent
  • clinical translation strategy of engineered MSCs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 525 KB  
Review
Mesenchymal Stem Cell Sheet Engineering: Refining Cell Delivery Strategies in Regenerative Medicine
by Delger Bayarsaikhan, Yoon Joong Kang, Ji Yeon Oh, Teruo Okano, Bonghee Lee and Kyungsook Kim
Bioengineering 2026, 13(2), 250; https://doi.org/10.3390/bioengineering13020250 - 20 Feb 2026
Viewed by 1086
Abstract
Mesenchymal stem cells (MSCs) have been widely investigated in regenerative medicine owing to their immunomodulatory activity, paracrine signaling, and multilineage differentiation potential. However, accumulating clinical and preclinical evidence indicates that conventional MSC therapies based on single-cell injection often produce transient benefits due to [...] Read more.
Mesenchymal stem cells (MSCs) have been widely investigated in regenerative medicine owing to their immunomodulatory activity, paracrine signaling, and multilineage differentiation potential. However, accumulating clinical and preclinical evidence indicates that conventional MSC therapies based on single-cell injection often produce transient benefits due to rapid post-transplant cell loss and poor engraftment. These observations suggest that the limited efficacy of MSC therapy is not determined solely by cell type or disease context but may also be influenced by the delivery strategy. In this review, we focus on MSC-based cell sheet studies as an approach to improve cell retention and therapeutic persistence. Building on the clinical validation of cell sheet technology, we critically summarize preclinical evidence across distinct tissue environments. Preclinical studies in cardiac and cutaneous repair models demonstrate that MSC sheets enhance cell retention, sustain paracrine signaling, and promote tissue-level regeneration. Together, these findings highlight that effective MSC sheet therapy requires organ-specific, cell-source-dependent design strategies rather than a uniform approach across tissues. Finally, we propose that the MSC sheet engineering represents not a technical adjustment, but a conceptual shift from transient cell delivery toward structurally integrated, tissue-level regeneration engineering. Full article
(This article belongs to the Special Issue Engineering Mesenchymal Stem Cells for Regenerative Medicine)
Show Figures

Graphical abstract

Back to TopTop